US 10,888,575 B2
Combination comprising zidovudine and a carbapenem
Anthony Coates, London (GB); and Yanmin Hu, London (GB)
Assigned to HELPERBY THERAPEUTICS LIMITED
Appl. No. 16/317,512
Filed by HELPERBY THERAPEUTICS LIMITED, London (GB)
PCT Filed Jul. 11, 2017, PCT No. PCT/GB2017/052030
§ 371(c)(1), (2) Date Jan. 11, 2019,
PCT Pub. No. WO2018/011562, PCT Pub. Date Jan. 18, 2018.
Claims priority of application No. 1612093.3 (GB), filed on Jul. 12, 2016.
Prior Publication US 2019/0321384 A1, Oct. 24, 2019
Int. Cl. A61K 31/7072 (2006.01); A61P 31/04 (2006.01); A61K 31/407 (2006.01); A61K 38/12 (2006.01)
CPC A61K 31/7072 (2013.01) [A61K 31/407 (2013.01); A61K 38/12 (2013.01); A61P 31/04 (2018.01)] 13 Claims
 
1. A combination comprising zidovudine or a pharmaceutically acceptable salt and/or solvate thereof and a carbapenem or a pharmaceutically acceptable salt and/or solvate thereof, wherein the combination optionally further comprises at least one polymyxin selected from polymyxin B or polymyxin E, or at least one pharmaceutically acceptable salt and/or solvate thereof.